Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

nifenazone

Known as: N-antipyrinylnicotinamide, nicophezon, nikofezon 
 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (3)

Anti-Inflammatory Agents, Non-SteroidalAntipyrineNiacinamide

Narrower (1)

Nicopyron
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Pyrazolones Activate the Proteasome by Gating Mechanisms and Protect Neuronal Cells from β‐Amyloid Toxicity
Proteasome malfunction parallels abnormal amyloid accumulation in Alzheimer's Disease (AD). Here we scrutinize a small library of… Expand
2014
2014
The solvatochromic, spectral, and geometrical properties of nifenazone: a DFT/TD-DFT and experimental study.
The solvatochromic, spectral, and geometrical properties of nifenazone (NIF), a pyrazole-nicotinamide drug, were experimentally… Expand
  • table 1
  • figure 2
  • table 2
  • figure 3
  • figure 4
1985
1985
Photochemical decomposition of phenazone derivatives. Part 5(1): Isolation and identification of decomposition products in aqueous solution.
From aqueous solutions of phenazone, aminophenazone, propyphenazone, nifenazone, morazone, noramidopyrine, 4-aminophenazone and… Expand
1985
1985
[Nifenazone, biotransformation in humans].
 
1972
1972
Evaluation of liver function during administration of nifenazone in rheumatic disease on the basis of serum protein studies and enzyme tests.
 
1966
1966
[Synthesis of nicophezon: nicotinic acid 4-antipyrilamide].
 
1966
1966
[Synthesis of nicophezon: nicotinic acid 4-antipyrilamide].
 
1964
1964
Trial of Nifenazone (“Thylin”)
in contact with the patient's serum for one hour. Tests were carried out on admission, when the Donath-Landsteiner titre was 32… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE